Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT.
Herrera-Hidalgo L, Lomas-Cabezas JM, López-Cortés LE, Luque-Márquez R, López-Cortés LF, Martínez-Marcos FJ, de la Torre-Lima J, Plata-Ciézar A, Hidalgo-Tenorio C, García-López MV, Vinuesa D, Gutiérrez-Valencia A, Gil-Navarro MV, De Alarcón A. Herrera-Hidalgo L, et al. J Clin Med. 2021 Dec 21;11(1):7. doi: 10.3390/jcm11010007. J Clin Med. 2021. PMID: 35011748 Free PMC article.
Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy.
Herrera-Hidalgo L, López-Cortes LE, Luque-Márquez R, Gálvez-Acebal J, de Alarcón A, López-Cortes LF, Gutiérrez-Valencia A, Gil-Navarro MV. Herrera-Hidalgo L, et al. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00309-20. doi: 10.1128/AAC.00309-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32393486 Free PMC article.
Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs?
Herrera-Hidalgo L, de Alarcón A, López-Cortes LE, Luque-Márquez R, López-Cortes LF, Gutiérrez-Valencia A, Gil-Navarro MV. Herrera-Hidalgo L, et al. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e02099-20. doi: 10.1128/AAC.02099-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33046488 Free PMC article.
Corrigendum to "Ceftriaxone pharmacokinetics by a sensitive and simple LC-MS/MS method: Development and application" [J. Pharm. Biomed. Anal. 189 (2020) 113484].
Herrera-Hidalgo L, Gil-Navarro MV, Dilly Penchala S, López-Cortes LE, de Alarcón A, Luque-Márquez R, López-Cortes LF, Gutiérrez-Valencia A. Herrera-Hidalgo L, et al. J Pharm Biomed Anal. 2021 Jul 15;201:114098. doi: 10.1016/j.jpba.2021.114098. Epub 2021 Apr 29. J Pharm Biomed Anal. 2021. PMID: 33933703 No abstract available.
Erratum for Herrera-Hidalgo et al., "Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs?".
Herrera-Hidalgo L, de Alarcón A, López-Cortes LE, Luque-Márquez R, López-Cortes LF, Gutiérrez-Valencia A, Gil-Navarro MV. Herrera-Hidalgo L, et al. Antimicrob Agents Chemother. 2021 May 18;65(6):e00785-21. doi: 10.1128/AAC.00785-21. Print 2021 May 18. Antimicrob Agents Chemother. 2021. PMID: 34006611 Free PMC article. No abstract available.
34 results